4.6 Article

The Paucity of Evidence Supporting Screening for Stages 1-3 CKD in Asymptomatic Patients with or without Risk Factors

Journal

Publisher

AMER SOC NEPHROLOGY
DOI: 10.2215/CJN.02940314

Keywords

-

Funding

  1. Agency for Healthcare Research and Quality
  2. US Department of Veterans Affairs
  3. National Kidney Foundation
  4. International Kidney Foundation

Ask authors/readers for more resources

The American College of Physicians recently published a guideline on screening for CKD that recommends against screening for CKD in asymptomatic adults without risk factors. The generally accepted criteria for population-based screening for disease state that screening should improve important clinical outcomes while limiting harms for those individuals screened. However, CKD screening does not meet these criteria. There is currently no evidence evaluating or demonstrating benefits for providing early treatment for patients identified via screening who do not have risk factors. On the other hand, harms are associated with the screening and include false-positive results, unnecessary testing and treatment, and disease labeling.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available